AGLITTI, Andrea
 Distribuzione geografica
Continente #
AS - Asia 1.901
NA - Nord America 629
EU - Europa 303
SA - Sud America 70
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 2.911
Nazione #
HK - Hong Kong 1.689
US - Stati Uniti d'America 623
RU - Federazione Russa 82
SG - Singapore 78
IT - Italia 73
CN - Cina 64
BR - Brasile 61
DE - Germania 40
DK - Danimarca 24
GB - Regno Unito 21
IE - Irlanda 20
TR - Turchia 19
KR - Corea 14
UA - Ucraina 10
FI - Finlandia 8
SE - Svezia 8
IN - India 7
VN - Vietnam 7
NL - Olanda 5
PK - Pakistan 4
AR - Argentina 3
AT - Austria 3
BD - Bangladesh 3
FR - Francia 3
JP - Giappone 3
MX - Messico 3
CA - Canada 2
EC - Ecuador 2
EU - Europa 2
MY - Malesia 2
RO - Romania 2
TW - Taiwan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CO - Colombia 1
ES - Italia 1
GA - Gabon 1
HN - Honduras 1
IQ - Iraq 1
KE - Kenya 1
LB - Libano 1
LT - Lituania 1
NO - Norvegia 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SN - Senegal 1
VE - Venezuela 1
Totale 2.911
Città #
Hong Kong 1.689
Chandler 94
Princeton 70
Ann Arbor 69
Ashburn 66
Singapore 43
Woodbridge 31
Dallas 26
Jacksonville 26
Moscow 23
Dublin 20
Beijing 17
Izmir 17
Andover 15
Los Angeles 15
Washington 15
Nürnberg 13
Wilmington 12
Copenhagen 11
Munich 10
Naples 10
Houston 8
Nanjing 8
The Dalles 8
Salerno 7
São Paulo 7
Turku 7
Fairfield 6
Columbus 5
Norwalk 5
Redwood City 5
San Giorgio A Cremano 5
Amsterdam 4
Chennai 4
Frederiksberg 4
Guangzhou 4
Hebei 4
Jinan 4
London 4
Nanchang 4
Pontecagnano 4
Saint Petersburg 4
Bolzano 3
Brooklyn 3
Caxias do Sul 3
Contagem 3
Council Bluffs 3
Falls Church 3
Latina 3
Phoenix 3
Quận Bình Thạnh 3
Rome 3
Santa Clara 3
Ankara 2
Boardman 2
Charlotte 2
Chicago 2
Faisalabad 2
Haikou 2
Haiphong 2
Hanoi 2
Johannesburg 2
Kuala Lumpur 2
Mercato San Severino 2
Monte San Giovanni Campano 2
Nuremberg 2
Pellezzano 2
Poggiomarino 2
Salvador 2
San Diego 2
San Jose 2
Seattle 2
Shanghai 2
Taoyuan District 2
Tianjin 2
Tokyo 2
Aachen 1
Apucarana 1
Arraial do Cabo 1
Aversa 1
Baghdad 1
Baltimore 1
Bandar Seri Begawan 1
Barreiras 1
Belo Horizonte 1
Bengaluru 1
Boston 1
Brasília 1
Cambridge 1
Campo Formoso Municipality 1
Caracas 1
Caratinga 1
Castanhal 1
Catalão 1
Changsha 1
Chihuahua City 1
City of London 1
Coromandel 1
Curitiba 1
Dakar 1
Totale 2.506
Nome #
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 708
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 350
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 334
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 285
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 160
The diagnostic conundrum in non-alcoholic fatty liver disease 155
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 154
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection 117
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 100
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 82
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 78
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 71
Viral hepatitis: Milestones, unresolved issues, and future goals 63
Real‐Life Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Infected Patients with Chronic Kidney Disease 62
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 60
NAFLD and extra-hepatic comorbidities: Current evidence on a multi-organ metabolic syndrome 58
HCV point-of-care screening program and treatment options for people who use drugs in a metropolitan area of Southern Italy 51
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 50
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 30
Totale 2.968
Categoria #
all - tutte 8.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 4 5 5 8 9 8 13 6 21 5
2021/2022129 4 2 5 0 6 2 4 5 21 11 16 53
2022/2023190 19 14 23 17 16 48 0 16 18 2 12 5
2023/2024146 7 8 17 9 20 40 0 9 6 5 8 17
2024/2025349 2 8 4 10 20 47 73 23 33 30 48 51
2025/20261.777 281 937 559 0 0 0 0 0 0 0 0 0
Totale 2.968